FDA Expands Optune`s Glioblastoma Multiforme Indication
Fantastic news! The FDA acted quickly! They approved Optune for Newly Diagnosed Glioblastoma to be used in addition to the standard treatment!
It results in "the risk of progression or death was reduced by 37 percent "
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.curetoday.com/articles/fda-expands-optunes-glioblastoma-multiforme-indication?utm_source=Informz&utm_medium=Cure+Today&utm_campaign=CURE_Breaking_News_10-5-15
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines